Quantcast
Skip to content

Immune Responses in Severe COVID-19 Patients

On Demand

Speaker

dexi-chen

Dexi Chen

Professor and Director

In this webinar, you will discover: 

  • How the immune response in severe COVID-19 patients was assessed.
  • The change in the T-cell population for patients suffering from severe COVID-19.
  • Changes in expression of genes related to T-cell activation and differentiation.
  • How this information may help researchers understand the immune response to COVID-19 and inform treatment strategies.

The global patient mortality rate of COVID-19 has been 3-4% of confirmed cases since the outbreak first began. The response of the immune system may play a critical role in the disease progression, severity, and mortality of COVID-19, with some studies showing decreased T cells and natural killer cells in patients infected with SARS-CoV-2, the virus responsible for COVID-19.

Professor Dexi Chen, the Director of the Beijing Institute of Hepatology,  investigated the immune system of patients suffering from severe COVID-19. The study uncovered a decreased proportion of T-cells and downregulation of genes related to T-cell activation and differentiation in severe COVID-19 patients.

This information may help researchers understand the immune response to COVID-19 and inform treatment strategies for the disease.

For Research Use Only. Not For Use In Diagnostic Procedures.

All registrants will receive a link to watch the recorded replay.

Webinar brought to you by

merck-logo-rich-blue

Enter your details to attend this webinar on demand

Graphic depicting COVID-19 virus
Scroll To Top
Share via
Copy link